Navamedic ASA (OSL:NAVA)

Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 474.83 million. The enterprise value is 612.47 million.

Market Cap	474.83M
Enterprise Value	612.47M

Important Dates

The next confirmed earnings date is Friday, August 14, 2026.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 23.98 million shares outstanding. The number of shares has increased by 8.92% in one year.

Current Share Class	23.98M
Shares Outstanding	23.98M
Shares Change (YoY)	+8.92%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.75%
Owned by Institutions (%)	31.17%
Float	20.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	93.18
PS Ratio	0.83
PB Ratio	1.52
P/TBV Ratio	n/a
P/FCF Ratio	40.09
P/OCF Ratio	33.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 51.71.

EV / Earnings	-37.80
EV / Sales	1.07
EV / EBITDA	12.96
EV / EBIT	68.72
EV / FCF	51.71

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.65.

Current Ratio	1.47
Quick Ratio	0.76
Debt / Equity	0.65
Debt / EBITDA	4.33
Debt / FCF	17.28
Interest Coverage	0.52

Financial Efficiency

Return on equity (ROE) is -6.15% and return on invested capital (ROIC) is 3.47%.

Return on Equity (ROE)	-6.15%
Return on Assets (ROA)	0.95%
Return on Invested Capital (ROIC)	3.47%
Return on Capital Employed (ROCE)	1.70%
Weighted Average Cost of Capital (WACC)	5.84%
Revenue Per Employee	15.03M
Profits Per Employee	-426,342
Employee Count	38
Asset Turnover	0.97
Inventory Turnover	3.45

Taxes

In the past 12 months, Navamedic ASA has paid 4.99 million in taxes.

Income Tax	4.99M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.81% in the last 52 weeks. The beta is 0.23, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	-4.81%
50-Day Moving Average	20.55
200-Day Moving Average	22.06
Relative Strength Index (RSI)	45.25
Average Volume (20 Days)	13,355

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 571.24 million and -16.20 million in losses. Loss per share was -0.79.

Revenue	571.24M
Gross Profit	218.22M
Operating Income	8.91M
Pretax Income	-11.21M
Net Income	-16.20M
EBITDA	44.25M
EBIT	8.91M
Loss Per Share	-0.79

Balance Sheet

The company has 67.10 million in cash and 204.74 million in debt, with a net cash position of -137.64 million or -5.74 per share.

Cash & Cash Equivalents	67.10M
Total Debt	204.74M
Net Cash	-137.64M
Net Cash Per Share	-5.74
Equity (Book Value)	312.90M
Book Value Per Share	13.37
Working Capital	77.59M

Cash Flow

In the last 12 months, operating cash flow was 14.21 million and capital expenditures -2.37 million, giving a free cash flow of 11.85 million.

Operating Cash Flow	14.21M
Capital Expenditures	-2.37M
Depreciation & Amortization	28.33M
Net Borrowing	88.45M
Free Cash Flow	11.85M
FCF Per Share	0.49

Margins

Gross margin is 38.20%, with operating and profit margins of 1.56% and -2.84%.

Gross Margin	38.20%
Operating Margin	1.56%
Pretax Margin	-1.96%
Profit Margin	-2.84%
EBITDA Margin	7.75%
EBIT Margin	1.56%
FCF Margin	2.07%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.92%
Shareholder Yield	-8.92%
Earnings Yield	-3.41%
FCF Yield	2.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4